Increasingly it is recognized that social factors play a role in the development of health problems and their resolution. For example, the incidence of obesity has been shown to occur in clusters, with the development of obesity in one person increasing the odds that obesity will develop in their close friends \[[@R1]\]. These social processes have been harnessed as a means to improve outcomes in several approaches to behavioral weight loss. For example, Wing and colleagues \[[@R2]\] recruited participants with several of their friends and/or family members and treated these participants as a team, with group activities utilized to stress intra-group cohesion and inter-group competition. This social intervention improved overall weight loss outcomes.

Moreover, as would be expected with a social intervention, the study by Wing and colleagues found that there was a clustering in the weight loss outcomes among the team members; weight losses of one member of the team were found to be strongly related to that of the other members \[[@R2]\]. Similarly, when patients' friends or family members are included within the treatment program, the weight losses achieved by the patient and their social contacts are correlated with one another \[[@R3]\]. Such social contagion appears to extend even outside the program; the untreated spouses of patients in a behavioral weight loss program have been shown to achieve weight losses similar to the patients actually participating in the program \[[@R4]\]. Leahey and colleagues \[[@R5]\] recently reported that individual weight losses in a team-based weight loss program were influenced by the weight losses of others on the team, i.e. there was a clustering of outcomes; characteristics of the team at baseline influenced the results subsequently achieved\[[@R5]\].

It is less clear whether the characteristics of the other members of the group influence the weight losses achieved by the individual participants in standard group-based behavioral weight loss programs and whether these weight losses tend to cluster within the group. Typically, behavioral weight loss tested in research studies are conducted in a group format. Approximately 10--15 patients who do not know each other are treated together, with weekly meetings for 6 months, followed by less frequent meetings for extended periods of time \[[@R6]\]. These programs present a structured series of behavioral weight loss lessons and do not include emphasis on group cohesion or efforts to encourage group members to interact with each other outside of the group setting. Similarly, many other types of weight loss programs, such as Weight Watchers, Take Off Pounds Sensibly (TOPS), and lifestyle interventions to prevent diabetes that are offered through hospitals and YMCAs, utilize group approaches for the delivery of the program \[[@R7]\]. Weight losses achieved in group programs appear to surpass those seen with individual contact \[[@R8]\], and are clearly less costly to administer. However, to date there has been little research examining the group effects inherent in these programs.

A large number of studies have examined individual baseline characteristics that might predict treatment outcome (e.g., \[[@R9]\]) but few have examined whether the baseline characteristics of the group affect the outcome in behavioral weight loss studies. Studies of group performance suggest that characteristics such as the size of the group and the similarity of group members to each other might influence treatment outcomes \[[@R10], [@R11]\]. In the only study examining this within behavioral weight control interventions, Jeffery and colleagues \[[@R12]\] found no differences in the weight losses achieved by participants who were randomly assigned to groups that were homogeneous or heterogeneous with respect to gender and degree of overweight.

In addition, the extent to which performance (in terms of adherence or weight loss) clusters within groups has rarely been studied. Simon et al \[[@R13]\] analyzed the results of 13 different weight loss groups and observed that attendance during the 26 session program clustered within group (ICC=.14), but weight loss did not (ICC=.00). However, the relatively small number of weight loss groups and the fact that the mean weight losses in this trial were quite low (mean of 4.24 kg at12 months) may have limited the ability to see clustering.

Given that weight loss programs are often offered in group format, these issues have important clinical and methodological implications. Information about whether the size of the group or the characteristics of the group members, in terms of their diversity in age, gender, and BMI, affects the outcome could improve the results achieved in future programs. Evidence of significant clustering of outcomes within behavioral weight loss groups would have important methodological implications. Such clustering would need to be accounted for in estimating sample size and in data analysis \[[@R14]\]. Although clustering is often considered in sample size estimates for school-based and physician-based interventions, it is not typically considered in most clinical studies of weight loss interventions.

In this paper, we examine these questions using the Look AHEAD trial. Look AHEAD is a multicenter clinical trial comparing the effects of intensive lifestyle intervention (ILI) vs control on cardiovascular morbidity and mortality in over 5000 overweight/obese individuals with type 2 diabetes \[[@R15]\]. The fact that there were over 200 different ILI weight loss groups in this trial provides a unique opportunity to address two important questions: 1) Is there a clustering of outcomes within groups for adherence to treatment components and/or for the weight losses achieved?; 2) Do group characteristics (including size of the group and its composition) affect weight losses achieved? We focus primarily on weight losses at one year, because groups were meeting most frequently during this time.

Methods {#S5}
=======

Participants {#S6}
------------

As reported previously, to be included in Look AHEAD, participants had to have type 2 diabetes, be 45--76 years of age, have a BMI of \>25 kg/m^2^ (\>27 if taking insulin), with A1c \<11%, systolic blood pressure \<160 mmHg, diastolic blood pressure \<100 mmHg, and triglycerides \<600 mg/dl.\[[@R15]\] They were also required to complete a maximal fitness test. Look AHEAD recruited 5145 participants, with 59% females, and 37% from minority populations \[[@R16]\]. This analysis focused only on those individuals who were randomly assigned to the Intensive Lifestyle Intervention in the Look AHEAD trial.

Design/Procedures {#S7}
-----------------

Look AHEAD was conducted at 16 clinical sites within the United States. Participants were randomly assigned within clinical site to either the Intensive Lifestyle Intervention group (ILI) or to Diabetes Support and Education (DSE), the control group for this trial \[[@R15]\]. Participants in the ILI received a lifestyle intervention that has been described in detail \[[@R17]\]. This program was offered in a group format, with nutritionists, exercise physiologists, and behavioral psychologists serving as group leaders. Groups were formed according to participant availability. Our analyses focus primarily on clustering seen for outcomes achieved during the first year because the group contact was greatest during this time and participants typically remained in their assigned group throughout this period. During the first 6 months of the ILI program, participants attended one individual and 3 group meetings each month and during months 7--12 they attended one individual and two group meetings per month. Subsequently participants attended only one group meeting and had one individual contact per month. The goals of the intervention were to produce a mean weight loss of at least 7% of initial body weight (with participants each asked to try to lose 10% of their body weight) and to increase moderate intensity physical activity to 175 minutes per week. Participants were given a calorie and fat gram goal and were provided with liquid shakes and meal bars to help them adhere to this dietary regimen. The program focused on behavioral strategies, and emphasized self-monitoring, goal setting, and problem solving. Self-monitoring records were kept daily throughout the program and were reviewed each week by the lifestyle interventionists.

Measures {#S8}
--------

Demographic information was collected at baseline. Weight was assessed at baseline and annual assessments by clinic staff, who were masked to treatment assignment. Adherence metrics included attendance at treatment sessions (recorded by intervention staff), meal replacement use and minutes of moderate intensity physical activity (both obtained from participants' weekly self-monitoring records).

Statistical Methods {#S9}
-------------------

Look AHEAD assigned 2570 participants to ILI at baseline. For inclusion in analyses, participants must have returned for their Year 1 weight to be measured: this eliminated 95 participants (3.7%). Those who gained more than 20% or lost more than 30% were dropped from the analyses to reduce the effect of atypical cases: this eliminated 15 more participants. Finally, we restricted analyses to intervention groups with at least 6 participants to provide reasonably stable group means and variances for group characteristics and excluded clinical sites that conducted fewer than 6 groups, which excluded 131 additional participants, for a final database of 2329 (90.6%) of the enrolled ILI participants. General linear models, with intervention groups as random effects nested within clinical sites, were used to estimate intraclass correlations (ICCs) with varying levels of covariate adjustment. The ICC is the ratio of the between group variance compared to the sum of the between and within group variance. These were estimated using Proc Mixed in SAS (SAS Institute. SAS/STAT, V.9.3., 2008) using a random effects model, i.e. group was considered to be a random effect. Given that our goal was descriptive, no significance tests were conducted. Linear models and correlation coefficients were used to describe associations between group characteristics (including baseline BMI, gender, insulin use and age) and group weight change. Since race/ethnicity tended to cluster within clinic site, it was not included as a separate variable among the group characteristics we considered.

Results {#S10}
=======

Analyses included data from 2329 participants, who were members of 209 intervention groups, across 15 clinics. [Table 1](#T1){ref-type="table"} provides information on characteristics of the 209 groups. Group size averaged 11 members (range 6--21) and 58.9% of the group members were female (range 11.1--100%). The average group had 36.7% percent of its members with BMI of \<30 kg/m^2^, 33.2% with BMI of 30 to 34 kg/m^2^, 18.4% with BMI of 35 to 39, and 11.7% with BMI of 40 kg/m^2^ or more. The average (standard deviation; interquartile range) percent loss of body weight across the 209 groups was 8.64% (2.35; 6.82 to 10.32%). Very similar results were seen using weight loss in kilograms: mean weight loss of 8.78 kg (2.48; 7.10 to 10.63 kg).

Clustering of weight loss outcomes and adherence within groups. Controlling for any systematic differences among clinics (i.e. including a marker for site as a covariate) with treatment groups nested within clinics, the overall ICC for change in percent body weight at one year was 0.008. As a comparison, the ICC for age and baseline BMI were 0.192 and 0.026, respectively. With additional adjustment for four baseline factors known to influence weight loss (gender, initial BMI, age, and insulin use), the overall ICC was 0.007 ([Table 2](#T2){ref-type="table"}). [Table 2](#T2){ref-type="table"} also provides the adjusted ICCs for each clinic site. These were uniformly small, except for one site ("F"), for which the unadjusted and adjusted ICCs were 0.083 and 0.121, respectively. We also examined the ICC by year of enrollment in the trial, and found no consistent difference over time. The ICC for percent weight change at Year 4 was 0.000.

Three process measures were used to monitor intervention adherence: attendance at treatment sessions, use of meal replacements, and self-reported minutes of physical activity. The overall means (standard deviations) for these measures over the first year of intervention were 35.2 (7.7) visits, 7.3 (4.1) meal replacements per week, and 143 (109) minutes of exercise per week. Each of these adherence measures was significantly correlated with one year weight loss (r=0.38, r=0.34, and r=0.41, respectively, all p\<0.001). However, as seen in [Table 2](#T2){ref-type="table"}, these adherence measures, adjusted for clinic and baseline characteristics, each had much stronger within group ICCs than weight loss, and were substantial (e.g. \>0.10) for several clinic sites.

Between group effects for weight loss. As shown in [Figure 1](#F1){ref-type="fig"}, there was a fair amount of variability in the outcomes that were achieved across the 209 groups. While 46.4% of the groups had average weight losses between 8 and 11%, 14.8% had a weight loss of \<6%, and 8% had weight losses of \>12%.

We examined whether the average weight losses across the 209 intervention groups were associated with baseline group characteristics. In analyses controlling for differences among clinic sites, group size was not associated with mean weight loss (r= −0.04, p=0.57). However, the percentage of women in the group (r=−0.16; p=0.02); the average age of the group (r=0.18; 0=0.01); and the average baseline BMI (r=−0.49; p\<0.001) were all associated with the group's average weight loss. Adjusting for clinic reduced the standard deviation among the intervention groups from 2.35% to 2.09% and further adjustment for covariates (age, sex, insulin use and BMI) reduced it to 1.83%. Thus less than 25% of the variance among intervention between groups was explained by these variables.

We also examined the relationship of weight loss with measures of group heterogeneity. For this, we looked at the gender distribution (absolute difference from 50% female) and the intra-group standard deviation of age and initial BMI. These measures had mean (interquartile range) of 15.9 (0.0, 22.7), 5.8 years (4.6, 7.0), and 5.5 kg/m^2^ (4.4, 6.7), respectively. Variability in age and gender were not related to the groups' weight loss outcomes. Group mean weight losses tended to be lower among groups with greater heterogeneity in baseline BMI (r= −0.21, p=0.003), but this effect was removed after controlling for the group mean BMI (partial r = −0.08, p=0.27).

Discussion {#S11}
==========

Behavioral weight loss programs are typically offered in group formats \[[@R6]\]. Although these groups meet together over extended periods of time, the present data suggest that there is very little clustering of weight loss outcomes within standard behavioral weight loss groups. Thus, the outcome of the other group members appears to have little or no influence on the weight loss success of any one member. This finding, which replicates results reported by Simon and colleagues \[[@R13]\] across 13 therapy groups, has important methodological implications, as it suggests that weight loss studies need not account for clustering of outcomes in the power analyses or statistical approaches to the data analysis.

These findings also suggest that weight loss programs that seek to use social influence processes to improve outcome will need to provide more focused strategies, such as developing within-group activities or between group competitions, to accomplish this goal or alternatively, use existing relationships such as between friends or family members \[[@R3]\]. A recent study of weight loss in a team-based community intervention showed that individuals who reported greater social influence from their team achieved better weight losses\[[@R5]\]. Such social influence might be enhanced through group activities to develop shared norms or by increased social modeling of weight-related behaviors. In addition, individuals who are less successful at a task have been shown to perform better when doing a task with others, especially an interdependent task where every member of the group must succeed in order for the group to succeed \[[@R18]\]. This effect, referred to as the Kohler effect \[[@R19]\], has been shown to motivate higher levels of physical activity \[[@R20]--[@R22]\] and likely plays a role in the success of group-based contingencies in behavioral weight loss programs. Incorporating social influence strategies such as these may help improve weight loss outcomes. In contrast to the weight loss outcomes, adherence measures were more clustered within treatment group. Attendance, use of meal replacement products and minutes of physical activity all showed greater clustering within treatment group than did weight loss. Clustering of adherence outcomes may be stronger than clustering of weight loss due to the fact that weight loss is under more physiological control than behavioral outcomes. Alternatively, clustering may be seen more in self-report measures than in objective measures, because participants may bias the information they report to make them more similar to others in the group. Clustering of behavioral measures may also reflect group norms for adherence, social modeling of adherence behaviors, and/or diffusion of weight loss information among group members. For example, when some members of the group fail to attend treatment meetings, it may provide information, norms, and modeling of behavior, which then allows others to behave similarly, whereas success at weight loss remains more private.Another important finding is the heterogeneity in the outcomes seen across treatment groups, even after adjusting for participant characteristics expected to influence weight loss (such as gender and age). The mean weight loss across the 209 groups was 8.6%, exceeding the minimum study goal of 7%. Although participants in all groups were given the same weight and activity goals, and all groups had the same schedule and content of treatment lessons, there was a fair amount of variability in the outcomes achieved. This variability is of concern for smaller treatment development studies where the outcome observed in a limited number of groups is used to make decisions about the clinical efficacy of new treatment strategies. Some of this variability reflected the composition of the group and the same individual level variables (e.g. gender and age) that have been shown to influence initial weight loss \[[@R19]\]. However, much of the variability between groups was unaccounted for and may be largely a random phenomenon, consistent with the low intra-class correlations. Previous studies have documented marked variability among participants in the weight losses achieved \[[@R23]\], but this is the first study to show that group averages are also variable.

This study also suggests that the composition of the group has little effect on the outcomes achieved. Studies of group performance suggest that the homogeneity of the group, i.e. similarity among members of a group, may lead to greater cohesion and better outcomes \[[@R24], [@R25]\]. However, we found no evidence that the characteristics of the weight loss group, in terms of heterogeneity in age, weight, or gender distribution, affected the outcome, perhaps due to the restricted eligibility ranges used in this trial. Leahey likewise reported that group homogeneity did not affect weight loss outcomes\[[@R5]\]. Of particular interest was the finding that the size of the group did not affect the mean weight losses achieved; thus participants in smaller groups, who might be expected to receive more individual attention, did not achieve large weight losses. This is an interesting finding for clinicians who might want to consider the cost:effectiveness of delivering behavioral weight loss programs to groups of approximately 15--20 members.

There are several limitations of this study that need to be considered in interpreting the results. First, all Look AHEAD participants had diabetes, were between ages 45 and 76, and were willing to participate in a randomized clinical trial; these factors limited the heterogeneity of the sample and the generalizeability of the findings. In addition, efforts were made to maintain consistency of the intervention across sites and to maximize adherence in all participants; these efforts may have limited the effect of within-group variables. The treatment protocol involved both group and individual meetings, and the individual sessions, which are unusual to include in group-based programs, may have weakened the clustering of outcomes.

In summary, there appears to be little evidence that weight losses cluster among the members of a behavioral weight loss group, although somewhat greater effects were seen for adherence. Moreover, characteristics of the group in terms of size and homogeneity of the members have little effect on outcomes. Although treating participants in groups is clearly cost-effective, efforts to maximize the social aspects of group behavioral weight loss programs to improve treatment outcomes may be most successful if they utilize pre-existing relationships or extend beyond merely treating participants together in the same group and incorporate innovative strategies to affect group norms, group cohesion, and social influence processes.

This report is based primarily on data collected during year 1 of the Look AHEAD study. All investigators and staff involved in the baseline and 1-year results of Look AHEAD are listed below.
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###### 

Characteristics of the 209 Look AHEAD intervention groups included in analyses at enrollment.

  Characteristic of Group      Mean \[Range\]
  ---------------------------- ----------------------
  Group Size                   11.1 \[6, 21\]
                               
  Mean age, year               58.8 \[50.7, 67.1\]
                               
  Percent female               58.9 \[11.1, 100.0\]
                               
  Percent \> HS education      80.3 \[0.0 100.0\]
                               
  Percent race/ethnic groups   
    African-American           16.6 \[0.0, 90.9\]
    Hispanic                   14.7 \[0.0, 100.0\]
    Non-Hispanic white         64.8 \[0.0, 100.0\]
    Other/Multiple             3.8 \[0.0, 30.0\]
                               
  Percent insulin use          17.9 \[0.0, 62.5\]
                               
  Percent hypertensive         84.6 \[25.0, 100.0\]
                               
  Percent prior CVD            14.7 \[0.0, 50.0\]
                               
  Mean HbA1c (%)               7.24 \[6.17, 8.42\]
                               
  BMI distribution             
    % \<30 kg/m^2^             36.7 \[0.0, 85.7\]
    % 30--34 kg/m^2^           33.2 \[0.0, 82.4\]
    % 35--39 kg/m^2^           18.4 \[0.0, 66.7\]
    % ≥ 40 kg/m^2^             11.7 \[0.0, 50.0\]

###### 

Estimated intra-class correlations for percentage change in weight and adherence to lifestyle intervention at one year.

  ------------------------------------------------------------------------------------------
                       Intra-Class Correlation Among Intervention\                   
                       Groups[1](#TFN1){ref-type="table-fn"}                         
  -------------- ----- --------------------------------------------- ------- ------- -------
  A (153)        14    0.002                                         0.267   0.167   0.167

  B (165)        13    0.034                                         0.133   0.081   0.011

  C (151)        14    0.026                                         0.230   0.125   0.009

  D (143)        14    0.000                                         0.150   0.096   0.000

  E (166)        13    0.000                                         0.399   0.056   0.032

  F (157)        14    0.121                                         0.000   0.061   0.149

  G (147)        14    0.046                                         0.132   0.000   0.112

  H (150)        14    0.000                                         0.146   0.109   0.021

  I (151)        12    0.020                                         0.010   0.117   0.010

  J (138)        13    0.016                                         0.079   0.121   0.017

  K (152)        17    0.011                                         0.209   0.314   0.168

  L (166)        12    0.000                                         0.028   0.079   0.000

  M (158)        12    0.000                                         0.017   0.081   0.054

  N (160)        17    0.000                                         0.000   0.056   0.057

  O (167)        16    0.016                                         0.000   0.134   0.048

  Total (2342)   209   0.007                                         0.118   0.116   0.054
  ------------------------------------------------------------------------------------------

Intraclass correlation coefficient for intervention group after adjusting for clinical site, gender, baseline insulin use, age group, and baseline BMI

What is known {#S13}
=============

Behavioral weight loss programs are typically conducted in small groups of about 15 participants.

In behavioral weight loss programs utilizing social interventions (e.g. team-based competitions), the weight loss of the team members are related to each other.

It is unclear whether there is a clustering of outcomes in standard behavioral weight loss programs and whether the characteristics of the group in terms of size or homogeneity affects the weight losses achieved. If clustering leads to moderate levels of intra-class correlation, the statistical power available for comparing interventions may be lowered.

What does this study add {#S14}
========================

This study found that weight losses do not cluster within behavioral weight loss groups, i.e. the weight loss of one member of the group is independent of the other members. Thus statistical power will likely not be lowered.

Neither group size nor group homogeneity affected the weight losses achieved by the group.
